ស្វែងរក

បានបន្ថែមប្លុក ផ្សេងៗ

2025-08-26 08:28:44 -

Myelodysplastic Syndrome Drugs Market Rising with Demand for Combination Therapies

The global myelodysplastic syndrome drugs market size was estimated at USD 2.88 billion in 2023 and is projected to reach USD 5.28 billion by 2030, growing at a CAGR of 9.1% from 2024 to 2030. Myelodysplastic syndrome predominantly increases with age, most often occurring after the age of 65. The market growth is largely fueled by the introduction of novel therapeutics. The primary...

0 មតិយោបល់ 0 ភាគហ៊ុន 10 ទិដ្ឋភាព 0 ពិនិត្យ